- Home
- Labeler Index
- Glaxosmithkline Biologicals Sa
- 58160-912
- NDC Crossover: 58160-912 Fluarix 2025/2026
NDC Crossover 58160-912 Fluarix 2025/2026
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Influenza A Virus A/thailand/8/2022 Ivr-237 (h3n2) Antigen (formaldehyde Inactivated); Influenza A Virus A/victoria/4897/2022 Ivr-238 (h1n1) Antigen (formaldehyde Inactivated); Influenza B Virus B/austria/1359417/2021 Bvr-26 Antigen (formaldehyde Inactivated)
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 58160-912 – Fluarix 2025/2026, a vaccine label. This list includes other cross-matching products that share:
- The same product name: Fluarix 2025/2026
- OR Generic name: Influenza Virus Vaccine
- AND the same Administration Route: intramuscular
- OR Dosage Form: suspension
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
19515-904 | Flulaval 2025/2026 | Influenza Virus Vaccine | Suspension | Intramuscular | Id Biomedical Corporation Of Quebec | Vaccine |